-
10
-
-
0031610077
-
Cardiovascular disease and steroid hormone contraception: Report of a WHO scientific group
-
(1998)
WHO Tech Rep Ser
, vol.877
, pp. 1-89
-
-
-
11
-
-
0032574524
-
Using epidemiological data to guide clinical practice: Review of studies on cardiovascular disease and use of combined oral contraceptives
-
(1998)
BMJ
, vol.316
, pp. 984-987
-
-
Hannaford, P.C.1
Owen-Smith, V.2
-
14
-
-
0029564931
-
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
-
(1995)
Lancet
, vol.346
, pp. 1575-1582
-
-
-
18
-
-
0014431877
-
Investigation of relation between use of oral contraceptives and thromboembolic disease
-
(1968)
BMJ
, vol.2
, pp. 199-205
-
-
Vessey, M.P.1
Doll, R.2
-
22
-
-
13344260005
-
Effect of different progestogens in low dose oestrogen oral contraceptives on venous thromboembolic disease
-
(1995)
Lancet
, vol.346
, pp. 1582-1588
-
-
-
28
-
-
0031856577
-
Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism
-
(1998)
J Intern Med
, vol.244
, pp. 27-32
-
-
Bennet, L.1
Odeberg, H.2
-
34
-
-
0033017609
-
The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives
-
(1999)
Int J Fertil Womens Med
, vol.44
, pp. 19-30
-
-
Burnhill, M.S.1
-
39
-
-
0034679260
-
Risk of fatal pulmonary embolism with oral contraceptives
-
(2000)
Lancet
, vol.355
, pp. 2088
-
-
Poulter, N.R.1
-
40
-
-
0034702492
-
Third generation oral contraceptives
-
(2000)
BMJ
, vol.321
, pp. 190-191
-
-
Skegg, D.C.G.1
-
44
-
-
0029615479
-
Third-generation oral contraceptives: How risky?
-
(1995)
Lancet
, vol.346
, pp. 1570
-
-
Weiss, N.1
-
45
-
-
0030581824
-
Third generation oral contraception and venous thromboembolism
-
(1996)
BMJ
, vol.312
, pp. 68-69
-
-
McPherson, K.1
-
46
-
-
0032034139
-
Newer oral contraceptives and the risk of venous thromboembolism
-
(1998)
Contraception
, vol.57
, pp. 169-181
-
-
Walker, A.M.1
-
47
-
-
0033604120
-
The third generation oral contraceptive controversy: The evidence shows they are less safe than second generation pills
-
(1999)
BMJ
, vol.319
, pp. 795-796
-
-
O'Brien, P.A.1
-
48
-
-
0003193159
-
Combined oral contraceptives containing desogestrel or gestodene and the risk of venous thromboembolism
-
(1999)
Curr Probl Pharmacovigilance
, vol.25
, pp. 12
-
-
-
56
-
-
0029033740
-
Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
-
(1995)
Blood
, vol.85
, pp. 2756-2761
-
-
Koster, T.1
Rosendaal, F.R.2
Briët, E.3
-
70
-
-
0028290275
-
Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa
-
(1994)
J Biol Chem
, vol.269
, pp. 18735-18738
-
-
Shen, L.1
Dahlbäck, B.2
-
83
-
-
0033947981
-
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: A randomized cross-over study of two low-dose oral contraceptives
-
(2000)
Thromb Haemost
, vol.84
, pp. 9-14
-
-
Meijers, J.C.M.1
Middeldorp, S.2
Tekelenburg, W.3
-
89
-
-
4243280555
-
-
Wellington, New Zealand: New Zealand Department of Health, December. (See http://www.medsafe.govt.nz/Profs/PUarticles.htm.) (See NAPS document no. 05591 for 3 pages, c/o Microfiche Publications, 248 Hempstead Tpke., West Hempstead, NY 11552.)
-
(1998)
Deaths with third generation oral contraceptives
-
-
-
93
-
-
0031870121
-
Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study
-
(1998)
Contraception
, vol.57
, pp. 315-324
-
-
-
94
-
-
0030065643
-
Thrombosis, phlebitis and varicose veins
-
(1996)
BMJ
, vol.312
, pp. 198-199
-
-
Campbell, B.1
|